Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Development and Implementation of Intensified Bioprocessing for Biologics... Hang Zhou at WuXi Biologics and Huan Xiong at Repligen Full Title: Development and Implementation of Intensified Bioprocessing for Biologics Manufacturing There are increasing needs for flexibility and sp... 2 years ago | 93 mins Design, Content & Vision - Working Together Marjola Begaj, Founder & CEO @ Mab Innovations Ltd - Beyond Codes: A Partnership between Humans, Business & Technologies In today’s AI, IoT/E environment, being it properly technical or business & social, smart and agile does not necessary meet. The data and the technolo... 3 years ago | 34 mins Cost Considerations for the Application of Continuous Processing Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells Cost contribution of continuous manufacturing both in operational and capital expenditure in Monoclonal antibody production. Evaluating cost of produc... 3 years ago | 62 mins CONTINUOUS MANUFACTURING OF BIOLOGICS: A JOURNEY FROM CONCEPT TO REALITY Himanshu Gadgil at Enzene Biosciences Ltd and Ganesh Kumar, at Sartorius Full Title: Opportunities and Challenges in Developing a Fully-Connected Continuous Manufacturing Process for Biologics Insights through case studies... 2 years ago | 113 mins A Comprehensive Approach to Assess the Impact of Microbial Impurities on Pat... Dr Friedrich von Wintzingerode, QC Lead iNeST Project at Roche and Shabnam Solati, CEO & Co-Founder at CTL-MAT FULL TITLE: A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics Presented by Dr ... 3 years ago | 80 mins Mixed mode Chromatography in Purifying biologics - Overview Vivek Halan Zumutor Biologics Pvt Ltd, Bangalore, India This Webinar will discuss MMC in purifying biologics which includes monoclonal antibodies (mAbs), Bispecific antibodies (BsAbs), antibody fragments (S... 4 years ago | 41 mins Effect of Cell Culture Process Change from Fed-batch to Continuous on... Ru Zang, Associate Director at Mersana Therapeutics and John Bonham Carter,Project Line Lead at Repligen EFFECT OF CELL CULTURE PROCESS CHANGE FROM FED-BATCH TO CONTINUOUS ON PRODUCTIVITY AND PRODUCT QUALITY Integrated continuous bioprocessing has attrac... 4 years ago | 76 mins Mass Spec - an Essential Tool for Characterization of mAbs during Development Dr Wei Xu & Dr Henry Shion Monoclonal antibodies (mAbs) represent a big portion of therapeutic proteins. Mass spectrometry (MS) coupled with modern separation technologies has b... 7 years ago | 75 mins Mixed mode Chromatography in Purifying biologics - Overview Vivek Halan Zumutor Biologics Pvt Ltd, Bangalore, India This Webinar will discuss MMC in purifying biologics which includes monoclonal antibodies (mAbs), Bispecific antibodies (BsAbs), antibody fragments (S... 4 years ago | 42 mins Challenges and Successes in Externalization of the ADC Supply Chain Firelli Alonso, Ph.D. Sourcing for the manufacture and control of Antibody-Drug Conjugates (ADCs) used in clinical trials requires strategic planning, establishment of a sp... 6 years ago | 74 mins
